(3-hydroxypyrrolidin-2-yl)-[4-[6-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)-2-pyridinyl]piperazin-1-yl]methanone

C28H38N4O2 — CID 67261791

IUPAC(3-hydroxypyrrolidin-2-yl)-[4-[6-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)-2-pyridinyl]piperazin-1-yl]methanone
SMILESCC1(C)CCC(C)(C)c2cc(-c3cccc(N4CCN(C(=O)C5NCCC5O)CC4)n3)ccc21
InChIInChI=1S/C28H38N4O2/c1-27(2)11-12-28(3,4)21-18-19(8-9-20(21)27)22-6-5-7-24(30-22)31-14-16-32(17-15-31)26(34)25-23(33)10-13-29-25/h5-9,18,23,25,29,33H,10-17H2,1-4H3
InChIKeyLFRKSRSMBXLFHO-UHFFFAOYSA-N
MW462.64 g/mol
LogP3.47
Rot. Bonds3

About (3-hydroxypyrrolidin-2-yl)-[4-[6-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)-2-pyridinyl]piperazin-1-yl]methanone

(3-hydroxypyrrolidin-2-yl)-[4-[6-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)-2-pyridinyl]piperazin-1-yl]methanone (PubChem CID 67261791) has the molecular formula C28H38N4O2 and a molecular weight of 462.64 g/mol. Its IUPAC name is (3-hydroxypyrrolidin-2-yl)-[4-[6-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)-2-pyridinyl]piperazin-1-yl]methanone.

Molecular Properties

Compound Name(3-hydroxypyrrolidin-2-yl)-[4-[6-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)-2-pyridinyl]piperazin-1-yl]methanone
PubChem CID67261791
Molecular FormulaC28H38N4O2
Molecular Weight462.64 g/mol
Exact Mass462.30
IUPAC Name(3-hydroxypyrrolidin-2-yl)-[4-[6-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)-2-pyridinyl]piperazin-1-yl]methanone
SMILESCC1(C)CCC(C)(C)c2cc(-c3cccc(N4CCN(C(=O)C5NCCC5O)CC4)n3)ccc21
InChIInChI=1S/C28H38N4O2/c1-27(2)11-12-28(3,4)21-18-19(8-9-20(21)27)22-6-5-7-24(30-22)31-14-16-32(17-15-31)26(34)25-23(33)10-13-29-25/h5-9,18,23,25,29,33H,10-17H2,1-4H3
InChIKeyLFRKSRSMBXLFHO-UHFFFAOYSA-N
XLogP3.47
TPSA68.70 Ų
H-Bond Donors2
H-Bond Acceptors5
Rotatable Bonds3
Heavy Atoms34
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500462.64
LogP ≤ 53.47
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 105

Analyze (3-hydroxypyrrolidin-2-yl)-[4-[6-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)-2-pyridinyl]piperazin-1-yl]methanone with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (3-hydroxypyrrolidin-2-yl)-[4-[6-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)-2-pyridinyl]piperazin-1-yl]methanone?
The IUPAC name of (3-hydroxypyrrolidin-2-yl)-[4-[6-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)-2-pyridinyl]piperazin-1-yl]methanone (CID 67261791) is (3-hydroxypyrrolidin-2-yl)-[4-[6-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)-2-pyridinyl]piperazin-1-yl]methanone.
What is the SMILES notation for (3-hydroxypyrrolidin-2-yl)-[4-[6-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)-2-pyridinyl]piperazin-1-yl]methanone?
The canonical SMILES for (3-hydroxypyrrolidin-2-yl)-[4-[6-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)-2-pyridinyl]piperazin-1-yl]methanone is CC1(C)CCC(C)(C)c2cc(-c3cccc(N4CCN(C(=O)C5NCCC5O)CC4)n3)ccc21.
What is the InChIKey of (3-hydroxypyrrolidin-2-yl)-[4-[6-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)-2-pyridinyl]piperazin-1-yl]methanone?
The InChIKey is LFRKSRSMBXLFHO-UHFFFAOYSA-N. The full InChI is InChI=1S/C28H38N4O2/c1-27(2)11-12-28(3,4)21-18-19(8-9-20(21)27)22-6-5-7-24(30-22)31-14-16-32(17-15-31)26(34)25-23(33)10-13-29-25/h5-9,18,23,25,29,33H,10-17H2,1-4H3.
What are the key properties of (3-hydroxypyrrolidin-2-yl)-[4-[6-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)-2-pyridinyl]piperazin-1-yl]methanone?
(3-hydroxypyrrolidin-2-yl)-[4-[6-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)-2-pyridinyl]piperazin-1-yl]methanone has a molecular weight of 462.64 g/mol, XLogP of 3.47, 3 rotatable bonds, 2 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for (3-hydroxypyrrolidin-2-yl)-[4-[6-(5,5,8,8-tetramethyl-6,7-dihydronaphthalen-2-yl)-2-pyridinyl]piperazin-1-yl]methanone is sourced from PubChem (CID 67261791), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).